These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1361285)

  • 1. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
    Themido R; Loureiro M; Pecegueiro M; Brandão M; Campos MC
    Acta Derm Venereol; 1992 Sep; 72(5):361-4. PubMed ID: 1361285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
    Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
    Nyfors A
    Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):511-8. PubMed ID: 899789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan.
    Tang KT; Chen YM; Chang SN; Lin CH; Chen DY
    J Am Acad Dermatol; 2018 Oct; 79(4):652-658. PubMed ID: 29753054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
    Langman G; Hall PM; Todd G
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
    Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
    Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy.
    Rattanakaemakorn P; Pinyowiwat P; Iamsumang W; Chanprapaph K; Suchonwanit P
    Drug Des Devel Ther; 2021; 15():2299-2307. PubMed ID: 34093007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
    Ashton RE; Millward-Sadler GH; White JE
    J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver biopsies from psoriatics treated with methotrexate.
    Ho MS; Cheah E; Tham SN; Teh LB; Ng HS; Thirumoorthy S
    Ann Acad Med Singap; 1986 Apr; 15(2):210-4. PubMed ID: 3752896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia.
    Ng LC; Lee YY; Lee CK; Wong SM
    Int J Dermatol; 2013 Jan; 52(1):102-5. PubMed ID: 23278617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.